Omega Healthcare Investors (OHI) Cash & Equivalents (2009 - 2026)

Omega Healthcare Investors has disclosed Cash & Equivalents across 18 years of filings, most recently posting $26.1 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $26.1 million, down 92.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $26.1 million (down 92.89% YoY), and the FY2025 annual result was $27.0 million, down 94.79% from the prior year.
• Cash & Equivalents came in at $26.1 million for Q1 2026 at Omega Healthcare Investors, down from $27.0 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $737.2 million in Q3 2025 to a low of $6.9 million in Q3 2024.
• The 5-year median for Cash & Equivalents is $350.7 million (2023), against an average of $323.3 million.
• Across the five-year window, Cash & Equivalents tumbled 98.76% in 2024 and jumped 10636.76% in 2025, its largest moves.
• Omega Healthcare Investors' Cash & Equivalents stood at $297.1 million in 2022, then soared by 49.04% to $442.8 million in 2023, then increased by 17.06% to $518.3 million in 2024, then slumped by 94.79% to $27.0 million in 2025, then fell by 3.24% to $26.1 million in 2026.
• The last three Cash & Equivalents figures came in at $26.1 million (Q1 2026), $27.0 million (Q4 2025), and $737.2 million (Q3 2025), per Business Quant data.